NU577 Unit 5 Assignment: Management of Common STIs and Treatments

Student Name

Purdue University Globle 

NU577 NP II Clinical – Women’s Health Focus

Prof. Name

Date

NU577 Unit 5 Assignment: Management of Common STIs and Treatments

Sexually transmitted infections (STIs) such as trichomoniasis, syphilis, and chlamydia are managed through timely diagnosis, evidence-based antimicrobial therapy, partner treatment, and patient education. According to current CDC recommendations, trichomoniasis is typically treated with metronidazole, syphilis with benzathine penicillin G, and chlamydia with doxycycline. Early treatment helps prevent complications, reduces transmission, and improves patient outcomes in primary care and community health settings.

Understanding the Management of Common Sexually Transmitted Infections

Sexually transmitted infections remain a significant public health concern worldwide. Healthcare providers play an essential role in recognizing symptoms, confirming diagnoses, initiating appropriate treatment, and educating patients about prevention strategies. Effective STI management also includes partner notification, follow-up testing when indicated, and adherence to local public health reporting requirements.

Trichomoniasis

Trichomoniasis is caused by the protozoan parasite Trichomonas vaginalis. It is one of the most common nonviral STIs and frequently affects women of reproductive age. Although some individuals remain asymptomatic, many experience genitourinary symptoms that prompt clinical evaluation.

Clinical Presentation and Physical Findings

Patients with trichomoniasis may report:

• Vaginal itching or irritation

• Vaginal discomfort

• Increased vaginal discharge

• Dysuria (painful urination)

Physical examination findings may include:

• Strawberry cervix (punctate cervical hemorrhages)

• Thick or frothy vaginal discharge

• Vulvovaginal inflammation

Laboratory and Diagnostic Evaluation

Diagnosis is established through laboratory testing. Common diagnostic methods include:

• Wet mount microscopy (wet prep) to identify motile trichomonads

• Nucleic acid amplification testing (NAAT) for improved sensitivity and accuracy

NAAT is increasingly preferred in many clinical settings because it provides higher diagnostic sensitivity compared to microscopy.

Management and Treatment

The CDC recommends the following treatment for uncomplicated trichomoniasis:

• Metronidazole 500 mg orally twice daily for 7 days

Patients should complete the entire treatment regimen, even if symptoms resolve before the medication course is finished.

Patient Counseling and Education

Patient education is critical to reducing reinfection and transmission. Healthcare providers should advise patients to:

• Avoid sexual activity until treatment is completed and symptoms have resolved.

• Ensure all recent sexual partners receive treatment.

• Take medications exactly as prescribed.

• Use condoms consistently after recovery to reduce future STI risk.

• Return for follow-up testing approximately one month after treatment.

Referral Considerations

Referral is generally unnecessary unless complications, persistent symptoms, or coexisting infections are identified.

Syphilis

Syphilis is a bacterial infection caused by Treponema pallidum. The disease progresses through multiple stages and can affect nearly every organ system if left untreated. Early identification is essential because delayed treatment may result in neurological, cardiovascular, and systemic complications.

Clinical Presentation and Physical Findings

Patients with early syphilis may present with:

• Painless oral or genital ulcers

• Fever

• Fatigue

• Mucocutaneous lesions

• Elevated body temperature

Because symptoms vary by disease stage, clinicians should maintain a high index of suspicion when evaluating patients with unexplained lesions or systemic findings.

Laboratory and Diagnostic Evaluation

Syphilis is diagnosed using serologic testing, which typically includes:

• Nontreponemal tests (e.g., RPR or VDRL)

• Treponemal tests for confirmation

Patients exhibiting neurological symptoms may require additional evaluation to assess for neurosyphilis.

Management and Treatment

For uncomplicated syphilis, CDC guidelines recommend:

• Benzathine penicillin G (Bicillin L-A) 2.4 million units intramuscularly as a single dose

Patients with suspected neurological involvement should undergo further assessment and specialist consultation as needed.

Patient Counseling and Education

Patients should receive counseling regarding treatment expectations and potential adverse reactions. Important teaching points include:

• Seek immediate medical attention for mental status changes or neurological symptoms.

• Notify and encourage sexual partners to undergo testing and treatment.

• Practice safer sex by using condoms consistently.

• Understand the possibility of experiencing a Jarisch-Herxheimer reaction within 24 hours of treatment.

Common symptoms of a Jarisch-Herxheimer reaction include:

• Fever

• Headache

• Muscle aches

• Malaise

Follow-up serologic testing is recommended to monitor treatment response and disease resolution.

Referral Considerations

Syphilis is a reportable disease in many regions. Healthcare providers should comply with local and state public health reporting requirements to facilitate partner notification and disease surveillance efforts.

Chlamydia

Chlamydia is a common bacterial STI caused by Chlamydia trachomatis. Many individuals do not exhibit symptoms, making routine screening especially important among sexually active populations. Untreated chlamydia may lead to pelvic inflammatory disease, infertility, and other reproductive complications.

Clinical Presentation and Physical Findings

Clinical manifestations may include:

• Vaginal discharge

• Thick white discharge

• Dysuria

• Minimal or absent symptoms

Because asymptomatic infections are common, many cases are identified during routine screening examinations.

Laboratory and Diagnostic Evaluation

The preferred diagnostic method is nucleic acid amplification testing (NAAT), which may be performed using:

• Vaginal swabs

• SureSwab or equivalent collection methods

• Urine specimens in selected patients

NAAT remains the gold standard due to its high sensitivity and specificity.

Management and Treatment

The CDC-recommended treatment for uncomplicated chlamydia is:

• Doxycycline 100 mg orally twice daily for 7 days

Patients should complete the full antibiotic course to ensure successful eradication of the infection.

Patient Counseling and Education

Healthcare providers should educate patients about prevention and symptom monitoring. Counseling recommendations include:

• Abstain from sexual activity until treatment is complete.

• Encourage sexual partners to undergo evaluation and treatment.

• Seek medical attention if symptoms worsen or new symptoms develop.

Patients should promptly report:

• Pelvic pain

• Fever

• Persistent vaginal discharge

• Dyspareunia (pain during sexual intercourse)

• Painful urination

Routine test-of-cure is not generally recommended for nonpregnant individuals unless there are concerns regarding treatment adherence, persistent symptoms, or reinfection.

Referral Considerations

Referral is typically not required for uncomplicated cases. However, patients with recurrent infections, suspected pelvic inflammatory disease, or fertility concerns may benefit from additional evaluation by a specialist.

Key Considerations for STI Prevention

Preventing sexually transmitted infections requires a combination of patient education, screening, and public health interventions. Healthcare providers should emphasize:

• Consistent and correct condom use.

• Regular STI screening for at-risk populations.

• Prompt treatment of infected individuals and their partners.

• Adherence to prescribed medications.

• Follow-up care when clinically indicated.

Early intervention not only improves individual health outcomes but also supports broader community efforts to reduce STI transmission rates.

References

Centers for Disease Control and Prevention. (2021). Chlamydial infections – STI treatment guidelines. Centers for Disease Control and Prevention. https://www.cdc.gov/std/treatment-guidelines/chlamydia.htm

Centers for Disease Control and Prevention. (2022). Syphilis – STI treatment guidelines. Centers for Disease Control and Prevention. https://www.cdc.gov/std/treatment-guidelines/syphilis.htm

NU577 Unit 5 Assignment: Management of Common STIs and Treatments

Centers for Disease Control and Prevention. (2022). Trichomoniasis – STI treatment guidelines. Centers for Disease Control and Prevention. https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm

NU577 Unit 5 Assignment: Management of Common STIs and Treatments.